UFP Technologies, Inc.

UFPT Healthcare Medical Devices

UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024. In the quarter to June 2026, revenue grew 15.1%, EPS grew 20.6%, free cash flow fell 35.8% and total debt fell 19.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

291.67 5.52 −1.86%
Market cap
$2.3B
P/E
31.2×
Fwd P/E
23.6×
Dividend yield
—
F-score
5/9
Altman Z
6.86
Beneish M
−2.57
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
28.33 21.75 25.03 22.89

+8 more quarters

P/S ratio
3.25 2.46 2.84 2.57
P/FCF ratio
33.37 21.49 21.65 17.60
P/Operating CF
131.44 466.54 101.59 42.85
P/B ratio
4.44 3.41 4.04 3.81
Price to Tangible BV
15.70 14.32 19.98 24.30
EV/Sales
3.44 2.67 3.05 2.81
EV/EBITDA
18.75 14.52 16.50 15.02
EV/Operating CF
30.38 20.00 20.02 16.90
EV/FCF
35.36 23.38 23.28 19.23
Quick Ratio
1.61 1.59 1.45 1.28
Current Ratio
3.00 2.91 2.69 2.41
Net Debt/EBITDA
3.71 4.64 4.89 5.04
Debt/Assets
19.30% 22.39% 22.81% 24.59%
Debt/Equity
0.28 0.34 0.35 0.40
Asset Turnover
0.96 0.92 0.94 0.93
Operating CF/Net income
0.75 0.18 0.96 2.19
Capex/Depreciation
(0.23) (0.34) (0.78) (0.69)
Interest Coverage
16.42 13.45 11.14 9.77
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
13.08% 13.63% 14.08% 12.34%
Intangible Assets out of Total Assets
0.49 0.50 0.52 0.52
Share Based Compensation of Revenue
1.85% 1.77% 1.61% 1.27%
Graham Net Nets
0.01 (0.01) (0.02) (0.03)
Graham Number
112.17 106.69 104.78 101.37
Earnings Yield
3.53% 4.60% 3.99% 4.37%
Free Cash Flow Yield
3.00% 4.65% 4.62% 5.68%
Revenue per Share
22.48 19.97 19.33 20.04
Operating CF per Share
2.02 0.42 2.19 4.66
Capex per Share
(0.15) (0.22) (0.50) (0.44)
Free Cash Flow per Share
1.87 0.20 1.69 4.22
Cash per Share
1.17 2.59 2.63 2.36
Shareholders Equity per Share
59.74 56.84 55.01 52.37
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
59.74 56.84 55.01 52.37
Free Cash Flow
14.46 1.52 12.98 32.55
Working Capital
156.59 147.09 126.14 115.75
Capital Expenditures
(1.15) (1.69) (3.86) (3.38)
Net Current Asset Value
15.41 (11.70) (30.20) (50.94)
EV/EBIT
22.57 17.56 19.93 18.06
Capex to Sales
0.01 0.01 0.03 0.02
Price to Operating Income
21.30 16.15 18.53 16.54
Other line items
Average Receivables
102.00 99.74 88.94 89.20
Average Payables
27.81 29.07 24.28 27.86
Average Inventory
92.65 91.91 87.20 87.42
Average Assets
658.28 658.66 642.04 645.66
Average Common Equity
423.96 399.77 383.32 366.53

Fold the line items

Columns are period end dates